ATYPICAL TERATOID/RHABDOID TUMOR (ATRT) OF THE CNS

Clinical trials for ATYPICAL TERATOID/RHABDOID TUMOR (ATRT) OF THE CNS explained in plain language.

Never miss a new study

Get alerted when new ATYPICAL TERATOID/RHABDOID TUMOR (ATRT) OF THE CNS trials appear

Sign up with your email to follow new studies for ATYPICAL TERATOID/RHABDOID TUMOR (ATRT) OF THE CNS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with incurable brain cancer: First-in-Human trial launches

Disease control Recruiting now

This early-stage trial is testing a new type of personalized cell therapy for children and young adults whose aggressive brain tumors have come back or not responded to standard treatments. Doctors take a patient's own immune cells, genetically modify them to target a protein (GP…

Matched conditions: ATYPICAL TERATOID/RHABDOID TUMOR (ATRT) OF THE CNS

Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

ATYPICAL TERATOID/RHABDOID TUMOR (ATRT) OF THE CNS

Get alerted when new ATYPICAL TERATOID/RHABDOID TUMOR (ATRT) OF THE CNS trials appear

New hope for kids with incurable brain cancer: First-in-Human trial launches